EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Engineering mesenchymal stem cells for premature ovarian failure: overcoming challenges and innovating therapeutic strategies

Zijun Yuan, Yinping Zhang, Xinyu He, Xiang Wang, Xingyue Wang, Siqi Ren, Jiahong Su, Jing Shen, Xiang Li, Zhangang Xiao

Theranostics · 2024 · 14 (17) · 6487-6515

DOI: 10.7150/thno.102641 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Theranostics, 2024. Verfasst von Zijun Yuan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China. Hauptthemen laut MEDLINE: Primary Ovarian Insufficiency, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 19-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Primary Ovarian InsufficiencyMesenchymal Stem CellsMesenchymal Stem Cell TransplantationHumansFemaleAnimalsTissue EngineeringClinical Trials as Topic

Stichwörter der Autor:innen

genetic engineeringheterogeneitymesenchymal stem cellspremature ovarian failuretissue engineering

Autor:innen und Institutionen

  • Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China.
  • Cell Therapy & Cell Drugs of Luzhou Key Laboratory, Luzhou, Sichuan, China.
  • Sichuan College of Traditional Chinese Medicine, Sichuan Mianyang 621000, China.
  • Department of Pharmacology, School of Pharmacy, Sichuan College of Traditional Chinese Medicine, Sichuan Mianyang 621000, China.
  • Luzhou People's Hospital, Luzhou, Sichuan, China.

Zitieren

APA

Yuan, Z., Zhang, Y., He, X., Wang, X., Wang, X., Ren, S., Su, J., Shen, J., Li, X., & Xiao, Z. (2024). Engineering mesenchymal stem cells for premature ovarian failure: overcoming challenges and innovating therapeutic strategies. Theranostics, 14(17), 6487-6515. https://doi.org/10.7150/thno.102641

Vancouver

Yuan Z, Zhang Y, He X, Wang X, Wang X, Ren S, et al. Engineering mesenchymal stem cells for premature ovarian failure: overcoming challenges and innovating therapeutic strategies. Theranostics. 2024;14(17):6487-6515. doi:10.7150/thno.102641

BibTeX
@article{Yuan2024,
  author = {Yuan, Zijun and Zhang, Yinping and He, Xinyu and Wang, Xiang and Wang, Xingyue and Ren, Siqi and Su, Jiahong and Shen, Jing and Li, Xiang and Xiao, Zhangang},
  title = {Engineering mesenchymal stem cells for premature ovarian failure: overcoming challenges and innovating therapeutic strategies},
  journal = {Theranostics},
  year = {2024},
  volume = {14},
  number = {17},
  pages = {6487--6515},
  doi = {10.7150/thno.102641}
}
Kostenlos starten →